SEC EDGAR CompanyFacts fact · point in time
KAIROS PHARMA, LTD.: intangible_assets
One fact, its scope and the complete path back to the official record.
Reported value
$188.000k{"amount": 188000, "concept": "us-gaap:FiniteLivedIntangibleAssetsNet", "currency": "USD"}- Entity
- KAIROS PHARMA, LTD.
- Metric
- intangible_assets
- Period
- as of 2026-03-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-09-01T14:37:07.507930+02:00
Raw response SHA-256
a016e6f1101ce4c42dce023667671a24…Official-identifier path
https://factanker.com/fact/sec/cik-0001962011/intangible-assets/2026-03-31 (CIK, metric, reporting date)History
- supersedes {"amount": 22000, "concept": "us-gaap:IntangibleAssetsNetExcludingGoodwill", "currency": "USD"} (evidence 0001493152-26-022796)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.